Andrew Pollack
FDA orders 23andMe to stop marketing DNA test kit
The Food and Drug Administration is demanding that 23andMe immediately cease all marketing for its main DNA service until it ...
Will the FDA’s proposed ban on trans fats open the door for a new generation of ‘healthy’ GM soybeans?
Agriculture companies have developed a soybean that produces oils low in unhealthy transfats, but will restaurants and food manufacturers accept ...
Federal court confirms stance on patenting genes, invalidates Down syndrome test patent
A federal judge has invalidated a patent for testing for Down syndrome, confirming a Supreme Court ruling in June that ...
New anti-GMO battleground: Genetically engineered yeast for medicines and fragrances
Andrew Pollack, who covers business and biotechnology at the New York Times, recently reported on the revolutionary new trend of ...
California Governor vetoes biotech bill that would have encouraged generic biosimilars
California bill SB 598, which would have required pharmacists to inform patients if they were being given 'biosimilars' instead of ...
Fight over genetically altered crops intensifies in Hawaii
The balmy tropical isles here seem worlds apart from the expansive cornfields of the Midwest, but Hawaii has become the ...
Gene therapy with a difference
Terri Ellsworth is convinced that her 12-year-old son Billy, who has Duchenne muscular dystrophy, is being helped by an experimental drug ...
Biotech food companies pledge transparency, launch GMOAnswers.com
With pressure growing to label genetically modified foods, the developers of biotechnology crops are starting a campaign to gain support ...
Myriad Genetics sues competitors for patent infringement
Myriad genetics is suing two competitors for infringing on patents not covered by the Supreme Court's ruling on human gene ...
After gene patent ruling, availability of gene tests could broaden
The following is an excerpt. Almost immediately after the Supreme Court ruled that human genes could not be patented, several laboratories announced ...
DIY biotechnology: Glowing trees
Hoping to give new meaning to the term “natural light,” a small group of biotech enthusiasts is trying to create ...
Supremes debate human gene patents, but are they too late?
The Supreme Court is poised to take up the highly charged question of whether human genes can be patented. But ...
Biotech firms lobby states to limit generic drug competition
Some of the nation’s biggest biotechnology companies are lobbying state-by-state to limit competition from genetic drugs; this could add billions ...
Foes of modified corn find support in a disputed study that links GM corn to greater health risks
Rats fed either genetically engineered corn or the herbicide Roundup had an increased risk of developing tumors, suffering organ damage ...
New prenatal testing can detect more genetic problems
A new method of prenatal testing that can detect more genetic problems in a fetus than ever before could be ...
Monsanto wins big award in a biotech patent case
A federal jury awarded $1 billion in damages to the crop biotechnology leader Monsanto on Wednesday, saying that its arch ...
New GM apple that won’t turn brown stirs concerns from NGOs, conventional growers
A genetically engineered apple that does not turn brown when sliced or bruised is in development. But it has much ...
Soviet entrepreneur holds fate of GM salmon
If Americans ever eat genetically engineered fast-growing salmon, it might be because of a Soviet biologist turned oligarch turned government ...